IE 11 is not supported. For an optimal experience visit our site on another browser.

FDA says J&J Covid vaccine booster data is limited


While FDA scientists did say there may be a benefit from a second Johnson & Johnson shot two months after an initial dose, the agency noted the data is limited. It’s not clear whether these concerns would be enough to delay emergency use authorization.